DROSPIRENONE/ETHINYLESTRADIOL DAILY EXELTIS 3mg/0.03mg FILM-COATED TABLETS

Introduction

Package Leaflet: Information for the User

Drospirenone/Ethinylestradiol Daily Exeltis 3 mg/0.03 mg Film-Coated Tablets EFG

Read this entire leaflet carefully before you start taking this medicine, because it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others, as it may harm them, even if their symptoms are the same as yours.
• If you experience any side effects, consult your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Important things to know about combined hormonal contraceptives (CHCs):

• They are one of the most reliable reversible contraceptive methods if used correctly.
• They slightly increase the risk of having a blood clot in the veins and arteries, especially in the first year or when restarting a combined hormonal contraceptive after a break of 4 weeks or more.
• Be alert and consult your doctor if you think you might have symptoms of a blood clot (see section 2 “Blood clots”).

Contents of the Package Leaflet

1. What is Drospirenone/Ethinylestradiol Daily Exeltis and what is it used for
2. What you need to know before you start taking Drospirenone/Ethinylestradiol Daily Exeltis
3. How to take Drospirenone/Ethinylestradiol Daily Exeltis
4. Possible side effects
5. Storage of Drospirenone/Ethinylestradiol Daily Exeltis

1. Package Contents and Additional Information

1. What is Drospirenone/Ethinylestradiol Daily Exeltis and what is it used for

Drospirenone/Ethinylestradiol is a contraceptive and is used to prevent pregnancy.

Each film-coated tablet contains a small amount of two different female hormones, called ethinylestradiol and drospirenone.

Contraceptives that contain two hormones are called combined contraceptives.

2. What you need to know before you start taking Drospirenone/Ethinylestradiol Daily Exeltis

General Considerations

Before starting to take drospirenone/ethinylestradiol, you should read the information about blood clots in section 2. It is particularly important that you read the symptoms of a blood clot (see section 2 "Blood Clots").

Before starting to take drospirenone/ethinylestradiol, your doctor will ask you some questions about your personal and family medical history. The doctor will also measure your blood pressure and, depending on your state of health, may perform other tests.

This prospectus describes several situations in which you should interrupt the use of drospirenone/ethinylestradiol, or in which the effect of drospirenone/ethinylestradiol may decrease.

In such situations, you should not have sexual intercourse or should take additional non-hormonal contraceptive precautions, for example, use of a condom or another barrier method.

Do not use the rhythm method or the temperature method. These methods may not be reliable since drospirenone/ethinylestradiol alters the monthly changes in body temperature and cervical mucus.

Drospirenone/ethinylestradiol, like other hormonal contraceptives, does not protect against HIV infection (AIDS) or any other sexually transmitted disease.

Do not take Drospirenone/Ethinylestradiol Daily Exeltis

You should not take drospirenone/ethinylestradiol if you have any of the conditions listed below. Inform your doctor if you have any of the conditions listed below. Your doctor will discuss other forms of contraception that would be more suitable.

• If you have (or have ever had) a blood clot in a blood vessel of the legs (deep vein thrombosis, DVT), in the lungs (pulmonary embolism, PE) or in other organs.

• If you know you have a disorder that affects blood clotting: for example, protein C deficiency, protein S deficiency, antithrombin III deficiency, factor V Leiden or antiphospholipid antibodies.
• If you need an operation or if you spend a lot of time without getting up (see section "Blood Clots").
• If you have ever had a heart attack or a stroke.
• If you have (or have ever had) angina pectoris (a condition that causes severe chest pain and may be the first sign of a heart attack) or a transient ischemic attack (TIA, temporary stroke symptoms).
• If you have any of the following diseases that may increase your risk of forming a clot in the arteries:

• Severe diabetes with blood vessel damage.
• Very high blood pressure.
• Very high levels of fat in the blood (cholesterol or triglycerides).
• A condition called hyperhomocysteinemia.

• If you have (or have ever had) a type of migraine called "migraine with aura".

• If you have (or have ever had) a liver disease and your liver function has not yet normalized.
• If your kidneys do not work well (renal insufficiency).
• If you have (or have ever had) a tumor in the liver.
• If you have (or have ever had), or are suspected of having breast cancer or cancer of the sex organs.
• If you have vaginal bleeding, whose cause is unknown
• If you are allergic to ethinylestradiol or drospirenone, or to any of the other components of this medication (including those listed in section 6). This may manifest with itching, rash, or inflammation.
• If you have hepatitis C and are taking medications that contain ombitasvir/paritaprevir/ritonavir and dasabuvir, glecaprevir/pibrentasvir or sofosbuvir/velpatasvir/voxilaprevir (see section "Other medications and Drospirenone/Ethinylestradiol Daily Exeltis").

Additional information on special populations

Children and adolescents

Drospirenone/Ethinylestradiol is not indicated for use in women who have not yet had their first menstrual period.

Women of advanced age

Drospirenone/Ethinylestradiol is not indicated for use after menopause.

Women with liver insufficiency

Do not take Drospirenone/Ethinylestradiol if you suffer from liver disease. See sections "Do not take Drospirenone/Ethinylestradiol Daily Exeltis" and "Warnings and precautions".

Women with renal insufficiency

Do not take Drospirenone/Ethinylestradiol if you are suffering from kidney malfunction or acute renal insufficiency. See sections "Do not take Drospirenone/Ethinylestradiol Daily Exeltis" and "Warnings and precautions".

Warnings and precautions

Consult your doctor or pharmacist before starting to take Drospirenone/Ethinylestradiol.

Tell your doctor if you suffer from any of the following conditions.

In some situations, you will need to be particularly careful while taking drospirenone/ethinylestradiol or any other combined contraceptive, and it may be necessary for your doctor to perform periodic checks. If the condition develops or worsens while you are taking drospirenone/ethinylestradiol, you should also inform your doctor.

• If a close relative has or has had breast cancer.
• If you have any liver or gallbladder disease.
• If you have diabetes.
• If you have depression.
• If you have Crohn's disease or ulcerative colitis (chronic inflammatory bowel disease).
• If you have hemolytic uremic syndrome (HUS, a blood clotting disorder that causes kidney failure).
• • If you have sickle cell anemia (a hereditary disease of red blood cells).
  • If you have high levels of fat in the blood (hypertriglyceridemia) or known family history of this condition. Hypertriglyceridemia has been associated with an increased risk of developing pancreatitis (inflammation of the pancreas).
  • If you need an operation or spend a lot of time without getting up (see section 2 "Blood Clots").
  • If you have just given birth, you are at a higher risk of developing blood clots. You should ask your doctor when you can start taking drospirenone/ethinylestradiol after childbirth.
  • If you have inflammation of the veins that are under the skin (superficial thrombophlebitis).
  • If you have varicose veins.
• If you have epilepsy (see "Other medications and Drospirenone/Ethinylestradiol Daily Exeltis").
• If you have systemic lupus erythematosus (SLE, a disease that affects your natural defense system).
• If you have a disease that may have appeared for the first time during pregnancy or during previous use of sex hormones (e.g., hearing loss, porphyria (a blood disease), gestational herpes (skin rash with blisters during pregnancy), Sydenham's chorea (a nervous disease in which involuntary movements appear)).
• If you have or have ever had chloasma (a skin discoloration, especially on the face and neck, known as "pregnancy spots"). In this case, you should avoid direct exposure to the sun or ultraviolet rays.
• If you experience symptoms of angioedema such as swelling of the face, tongue, and/or throat, and/or difficulty swallowing or urticaria along with difficulty breathing, consult your doctor immediately. Medications that contain estrogens may induce or worsen the symptoms of hereditary and acquired angioedema.

BLOOD CLOTS

The use of a combined hormonal contraceptive like drospirenone/ethinylestradiol increases your risk of developing a blood clot compared to not using it. In rare cases, a blood clot can block blood vessels and cause serious problems.

Blood clots can form:

• In the veins (this is called "venous thrombosis", "venous thromboembolism" or VTE).
• In the arteries (this is called "arterial thrombosis", "arterial thromboembolism" or ATE).

Recovery from blood clots is not always complete. In rare cases, there can be serious long-term effects or, very rarely, they can be fatal.

It is important to remember that the overall risk of a harmful blood clot due to drospirenone/ethinylestradiol is small.

HOW TO RECOGNIZE A BLOOD CLOT

Seek urgent medical attention if you notice any of the following signs or symptoms.

BLOOD CLOTS IN A VEIN

What can happen if a blood clot forms in a vein?

• The use of combined hormonal contraceptives has been associated with an increased risk of blood clots in the veins (venous thrombosis). However, these side effects are rare. They occur more frequently in the first year of use of a combined hormonal contraceptive.
• If a blood clot forms in a vein in the leg or foot, it can cause deep vein thrombosis (DVT).
• If a blood clot moves from the leg and lodges in the lung, it can cause a pulmonary embolism.
• In very rare cases, a clot can form in a vein of another organ such as the eye (retinal vein thrombosis).

When is the risk of developing a blood clot in a vein higher?

The risk of developing a blood clot in a vein is higher during the first year in which you take a combined hormonal contraceptive for the first time. The risk may also be higher if you start taking a combined hormonal contraceptive (the same medication or a different one) after an interruption of 4 weeks or more.

After the first year, the risk decreases, but it is always slightly higher than if you were not taking a combined hormonal contraceptive.

When you stop taking drospirenone/ethinylestradiol, your risk of developing a blood clot returns to normal within a few weeks.

What is the risk of developing a blood clot?

The risk depends on your natural risk of VTE and the type of combined hormonal contraceptive you are taking.

The overall risk of developing a blood clot in the leg or lung (DVT or PE) with drospirenone/ethinylestradiol is small.

• Out of 10,000 women who do not use a combined hormonal contraceptive and are not pregnant, about 2 will develop a blood clot in a year.
• Out of 10,000 women who use a combined hormonal contraceptive that contains levonorgestrel, norethisterone, or norgestimate, about 5-7 will develop a blood clot in a year.
• Out of 10,000 women who use a combined hormonal contraceptive that contains drospirenone, such as drospirenone/ethinylestradiol, between 9 and 12 women will develop a blood clot in a year.
• The risk of developing a blood clot will depend on your personal history (see "Factors that increase your risk of a blood clot" below).

Factors that increase your risk of a blood clot in a vein

The risk of having a blood clot with drospirenone/ethinylestradiol is small, but some conditions increase the risk. Your risk is higher:

• If you are overweight (body mass index or BMI over 30 kg/m2).
• If any of your close relatives have had a blood clot in the leg, lung, or other organ at a young age (i.e., before the age of 50). In this case, you may have a hereditary blood clotting disorder.
• If you need an operation or spend a lot of time without getting up due to an injury or illness or if you have a leg in a cast. You may need to stop using drospirenone/ethinylestradiol several weeks before surgery or while you have reduced mobility. If you need to stop using drospirenone/ethinylestradiol, ask your doctor when you can start using it again.
• As you get older (especially above 35 years).
• If you have given birth less than a few weeks ago.

The risk of developing a blood clot increases with the number of conditions you have.

Long-distance flights (more than 4 hours) may temporarily increase the risk of a blood clot, especially if you have any of the other risk factors listed.

It is important to inform your doctor if you suffer from any of the above conditions, even if you are not sure. Your doctor may decide that you should stop using drospirenone/ethinylestradiol.

If any of the above conditions change while you are using drospirenone/ethinylestradiol, for example, a close relative experiences a thrombosis without a known cause or you gain a lot of weight, inform your doctor.

BLOOD CLOTS IN AN ARTERY

What can happen if a blood clot forms in an artery?

Like a blood clot in a vein, a clot in an artery can cause serious problems. For example, it can cause a heart attack or a stroke.

Factors that increase your risk of a blood clot in an artery

It is important to note that the risk of a heart attack or stroke due to drospirenone/ethinylestradiol is very small, but it can increase:

• With age (above 35 years).
• If you smoke. When you use a combined hormonal contraceptive like drospirenone/ethinylestradiol, you are advised to stop smoking. If you are unable to stop smoking and are over 35 years old, your doctor may advise you to use a different type of contraceptive.
• If you are overweight.
• If you have high blood pressure.
• If any of your close relatives have had a heart attack or stroke at a young age (less than 50 years). In this case, you may also have a higher risk of having a heart attack or stroke.
• If you or any of your close relatives have a high level of fat in the blood (cholesterol or triglycerides).
• If you have migraines, especially migraines with aura.
• If you have a heart problem (valve disorder, heart rhythm disorder called atrial fibrillation).
• If you have diabetes.

If you have more than one of these conditions or if any of them are particularly severe, the risk of developing a blood clot may be increased even further.

If any of the above conditions change while you are using drospirenone/ethinylestradiol, for example, you start smoking, a close relative experiences a thrombosis without a known cause, or you gain a lot of weight, inform your doctor.

Drospirenone/Ethinylestradiol Daily Exeltis and cancer

It has been observed that breast cancer is slightly more common in women who use combined contraceptives, but it is not known if this is due to the treatment. For example, it may be that more tumors are detected in women who take combined contraceptives because they are examined by a doctor more frequently. The incidence of breast tumors decreases gradually after stopping hormonal contraceptives.

3. How to take Drospirenone/Ethinylestradiol Daily Exeltis

Each blister pack contains 21 active pink tablets and 7 white placebo tablets.

The two different types of colored tablets of drospirenone/ethinylestradiol are placed in order. One pack contains 28 tablets.

Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Take one drospirenone/ethinylestradiol tablet every day with some water if necessary. You can take the tablets with or without food, but every day at approximately the same time.

Do not get confused with the tablet: take a yellow tablet during the first 21 days, and then a white tablet during the last 7 days. Then, you should start taking a new blister pack (21 yellow tablets and 7 white tablets). Therefore, there is no tablet-free period between two blister packs.

Due to the different composition of the tablets, it is necessary to start with the first tablet located in the upper left corner and then take one tablet every day. To maintain the order, follow the direction of the arrows on the blister pack.

Preparing the blister pack

To keep track of the daily intake of the contraceptive, each drospirenone/ethinylestradiol blister pack includes seven adhesive strips with the days of the week printed on them. You should know the day of the week you will take the first tablet.

According to the day of the week you will start taking the tablets, you should choose the corresponding adhesive strip, for example, if you start on Wednesday, stick the one that indicates “WED” as the initial tablet. Then, you should stick the corresponding strip on the upper left part of the blister pack, in the “Start” position. This way, there is a day of the week indicated above each tablet, and you can visually check if you have taken a specific tablet. The arrows show the order in which the tablets should be taken.

During the 7 days you take the placebo tablets (withdrawal week), menstruation usually begins (also called withdrawal bleeding). Usually, menstruation starts on the second or third day after taking the last active yellow tablet of drospirenone/ethinylestradiol. Once you have taken the last white tablet, you should start the next blister pack, even if you have not finished bleeding. This means you should start the next blister pack on the same day of the week you started the previous one, and menstruation should take place during the same days every month.

If you take drospirenone/ethinylestradiol as indicated, you will also be protected against pregnancy during the 7 days you are taking the placebo tablets.

When can you start with the first blister pack?

• If you have not taken any hormonal contraceptive in the previous month.

Start taking drospirenone/ethinylestradiol on the first day of your cycle (i.e., the first day of your menstruation). If you start drospirenone/ethinylestradiol on the first day of your menstruation, you will be immediately protected against pregnancy. You can also start on days 2-5 of your cycle, but you should use additional contraceptive methods (e.g., a condom) during the first 7 days.

• Changing from another combined hormonal contraceptive, vaginal ring, or patch.

You can start taking drospirenone/ethinylestradiol preferably the day after taking the last active tablet of your previous contraceptive, but no later than the day after the withdrawal week of your previous contraceptive (or after taking the last inactive tablet of your previous contraceptive). When changing from a vaginal ring or patch, follow your doctor's recommendations.

• Changing from a progestin-only method (progestin-only pill, injection, implant, or intrauterine system).

You can change from the progestin-only pill at any time (if it is an implant or an IUD, on the day of its removal; if it is an injectable, when the next injection is due), but in all cases, it is recommended that you use additional contraceptive measures (e.g., a condom) during the first 7 days of tablet intake.

• After an abortion.

Follow your doctor's recommendations.

• After having a child.

You can start taking drospirenone/ethinylestradiol between 21 and 28 days after having a child. If you start later than day 28, you should use a barrier method (e.g., a condom) during the first 7 days of drospirenone/ethinylestradiol use.

If, after having a child, you have already had sexual intercourse before starting to take drospirenone/ethinylestradiol again, you should be sure you are not pregnant or wait for your next period.

• If you are breastfeeding and want to start taking drospirenone/ethinylestradiol again after having a child.

Read the section “Breastfeeding”.

Ask your doctor if you are not sure when to start.

If you take more Drospirenone/Ethinylestradiol Daily Exeltis than you should

No cases have been reported where an overdose of drospirenone/ethinylestradiol has caused serious harm.

The symptoms that may appear if you take many tablets at once may include feeling unwell or vomiting or vaginal bleeding. This bleeding may occur even in girls who have not yet had their first period, if they have accidentally taken this medication.

If you have taken too many drospirenone/ethinylestradiol tablets, or discover that a child has taken them, consult your doctor or pharmacist immediately or call the Toxicology Information Service 91 562 04 20 indicating the medication and the amount used.

If you forget to take Drospirenone/Ethinylestradiol Daily Exeltis

The tablets in the fourthrow of the blister pack are placebo tablets. If you forget to take one of these tablets, the effect of drospirenone/ethinylestradiol will not be affected. You should discard the forgotten placebo tablet to not prolong the withdrawal week, which could have a negative effect on the efficacy of the drospirenone/ethinylestradiol tablets.

If you forget to take a tablet from the 1st, 2nd, or 3rdrow, you should follow these recommendations:

• If you are less than 12 hourslate in taking an active tablet, the protection against pregnancy will not decrease. Take the tablet as soon as you remember and the following tablets at the usual time.
• If you are more than 12 hourslate in taking an active tablet, the protection against pregnancy may be reduced. The more tablets you have forgotten, the higher the risk of becoming pregnant.

The risk of incomplete protection against pregnancy is maximum if you forget to take a tablet at the beginning of the blister pack (1st row) or at the end of the 3rd week (3rd row of the blister pack). Therefore, you should take the following measures (see also the diagram below):

• Forgetfulness of more than one tablet from the blister pack

Consult your doctor.

• Forgetfulness of a tablet in week 1

Take the forgotten tablet as soon as you remember, even if it means taking two tablets at the same time. Continue taking the following tablets at the usual time and use additional precautions, for example, a condom, during the next 7 days. If you have had sexual intercourse in the week before forgetting the tablet, you may be pregnant. In that case, consult your doctor.

• Forgetfulness of a tablet in week 2

Take the forgotten tablet as soon as you remember, even if it means taking two tablets at the same time. Continue taking the following tablets at the usual time. The protection against pregnancy will not decrease, and you do not need to take additional precautions.

• Forgetfulness of a tablet in week 3

You can choose between two options:

1. Take the forgotten tablet as soon as you remember, even if it means taking two tablets at the same time. Continue taking the following tablets at the usual time. Instead of taking the 7 white placebo tablets (withdrawal week), start taking the next blister pack.

You will probably have menstruation (withdrawal bleeding) at the end of the second blister pack, although you may experience light bleeding or spotting during the intake of the second blister pack.

1. You can also stop taking the active yellow tablets and go directly to the 7 white placebo tablets (you must note the day you forgot to take the tablet). If you want to start a new blister pack on your fixed start day, take the placebo tablets for less than 7 days.

If you follow one of these two recommendations, you will remain protected against pregnancy.

• If you have forgotten to take a tablet and do not have your period during the withdrawal week, you may be pregnant. In that case, you must see your doctor before continuing with the next blister pack.

What to do in case of vomiting or severe diarrhea?

If you vomit within 3-4 hours after taking an active tablet, or if you have severe diarrhea, there is a risk that the active ingredients of the contraceptive will not be fully absorbed by the body. This is similar to what happens when you forget a tablet. After vomiting or diarrhea, you should take a tablet from a reserve blister pack as soon as possible. If possible, within 12 hoursafter the usual time you take your contraceptive. If it is not possible or more than 12 hours have passed, follow the advice in the section “If you forget to take Drospirenone/Ethinylestradiol Daily Exeltis”.

Delayed menstrual period: what should you know?

Although it is not recommended, you can delay your menstrual period (withdrawal bleeding) if you start taking a new blister pack of drospirenone/ethinylestradiol instead of continuing with the withdrawal week and finish it. You may experience light bleeding or spotting during the intake of the second blister pack. After the usual withdrawal week, in which you take the 7 white tablets, start the next blister pack.

You should ask your doctor for advice before deciding to delay your menstrual period.

Changing the first day of your period: what should you know?

If you take the tablets as instructed, your menstrual period will begin during the withdrawal week. If you need to change the day, you can do so by shortening (but never lengthening! - 7 is the maximum) the withdrawal week. For example, if your withdrawal week starts on Friday and you want to change to Tuesday (3 days earlier), you should start a new blister pack 3 days earlier than usual. If you make the withdrawal week very short (e.g., 3 days or less), you may not experience bleeding during these days. Then you may experience light bleeding or spotting.

If you are not sure how to proceed, consult your doctor.

If you stop treatment with Drospirenone/Ethinylestradiol Daily Exeltis

You can stop taking drospirenone/ethinylestradiol whenever you want. If you do not want to become pregnant, consult your doctor about other effective birth control methods. If you want to become pregnant, stop taking drospirenone/ethinylestradiol and wait until your next period before trying to become pregnant. This way, you will be able to calculate the estimated date of delivery more easily.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.

If you experience any adverse effect, especially if it is severe and persistent, or have any change in health that you think may be due to drospirenone/ethinylestradiol, consult your doctor.

All women who take combined hormonal contraceptives are at a higher risk of developing blood clots in the veins (venous thromboembolism (VTE)) or blood clots in the arteries (arterial thromboembolism (ATE)). For more detailed information on the different risks of taking combined hormonal contraceptives, see section 2 "What you need to know before taking Drospirenone/Ethinylestradiol Daily Exeltis".

Severe Adverse Effects

Contact a doctor immediately if you experience any of the following symptoms of angioedema: swelling of the face, tongue and/or throat, and/or difficulty swallowing or urticaria with possible difficulty breathing (see also the "Warnings and Precautions" section).

The following list of adverse effects has been related to the use of drospirenone/ethinylestradiol.

Frequent Adverse Effects(may affect up to 1 in 10 patients):

• Menstrual disorders, intermenstrual bleeding, breast pain, breast tenderness.
• Headache, depressive mood.
• Migraine.
• Nausea.
• Thick white vaginal discharge and vaginal fungal infection.

Uncommon Adverse Effects(may affect up to 1 in 100 patients):

• Increased breast size, changes in sexual interest.
• High blood pressure, low blood pressure.
• Vomiting, diarrhea.
• Acne, skin rash, intense itching, hair loss (alopecia).
• Vaginal infection.
• Fluid retention and changes in body weight.

Rare Adverse Effects(may affect up to 1 in 1,000 patients):

• Allergic reactions (hypersensitivity), asthma.
• Breast secretion.
• Hearing problems.
• Skin disorders such as erythema nodosum (characterized by painful nodules on the skin of a reddish color) or erythema multiforme (characterized by a skin rash with target-like redness or ulcers).
• Harmful blood clots in a vein or artery, for example:

• In a leg or foot (i.e., DVT).
• In a lung (i.e., PE).
• Heart attack.
• Stroke.
• Mild stroke or temporary symptoms similar to those of a stroke, called a transient ischemic attack (TIA).
• Blood clots in the liver, stomach/intestine, kidneys, or eye.

The possibility of having a blood clot may be higher if you have any other condition that increases this risk (see section 2 for more information on conditions that increase the risk of blood clots and symptoms of a blood clot).

Reporting of Adverse Effects:

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Drospirenone/Ethinylestradiol Daily Exeltis

Keep this medicine out of the sight and reach of children.

This medicine does not require special storage conditions.

Do not take this medicine after the expiration date that appears on the packaging after CAD or EXP. The date is the last day of the month indicated.

Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines you no longer need at the SIGRE Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.

6. Package Contents and Additional Information

Composition of Drospirenone/Ethinylestradiol Daily Exeltis

A blister pack contains 21 active yellow tablets in rows 1, 2, and 3 of the blister pack and 7 white placebo tablets in row 4.

Active Tablets:

The active ingredients are 0.03 mg of ethinylestradiol and 3 mg of drospirenone.

The other components are:

Tablet core: lactose monohydrate, cornstarch, pregelatinized cornstarch, crospovidone, povidone, polysorbate 80, magnesium stearate.

Coating: partially hydrolyzed polyvinyl alcohol, titanium dioxide (E-171), macrogol 3350, talc, and yellow iron oxide (E-172).

Placebo Tablets:

Tablet core: anhydrous lactose, povidone, magnesium stearate.

Coating: partially hydrolyzed polyvinyl alcohol, titanium dioxide (E-171), macrogol 3350, talc.

Appearance of Drospirenone/Ethinylestradiol Daily Exeltis and Package Contents

The active tablets are film-coated, round, yellow tablets.

The placebo tablets are film-coated, round, white tablets.

• It is available in boxes of 1, 2, 3, 6, and 13 blister packs, each with 28 tablets (21 active tablets and 7 placebo tablets).

Only some package sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Exeltis Healthcare, S.L.

Pol. Ind. Miralcampo, Avda. de Miralcampo 7, 19200

Azuqueca de Henares,

Guadalajara, Spain

Manufacturer

Laboratorios León Farma, S.A.

Pol. Ind. Navatejera, C/ La Vallina, s/n

24193 - Villaquilambre, León

Spain

Date of the Last Revision of this Prospectus:November 2023

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) https://www.aemps.gob.es./